Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy

NCT ID: NCT03227380

Last Updated: 2017-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-31

Study Completion Date

2018-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to determine whether stapling adversely affects the pulmonary parenchyma and the vascularisation of the adjacent segments. The aim of our work is to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy, 3 or 6 months post-surgery. the investigator will assess venous drainage and the arterial vascularisation of the remaining segments, possible modifications of the adjacent parenchyma and whether there is a defect of pleuro-pulmonary adhesion (residual pneumothorax).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Scheduled anatomical segmentectomies are increasingly popular, due to the development of minimally invasive techniques, the increased incidence of early-stage tumours, and the possibility of caring for patients with compromised health and/or limited respiratory function without compromising the oncological outcome, compared to current alternatives such as stereotactic ablative radiotherapy (1).

One of the challenges in the development of the thoracoscopic segmentectomy technique we have published (2-5) is the orientation (6-7) and the division of the intersegmental plane, by contrast to segmentectomy by thoracotomy where this is helped by palpation and the manual traction which can be used on the segment, along the intersegmental vein. The most commonly used technique to separate two adjacent segments remains stapling, despite its high cost and sometimes giving a less anatomical section, with a risk to encroach on the intersegmental vein. Moreover, there can be a partial plicator of the spared segment(s) which could in theory make them less functional.

We have however shown that the postoperative morbidity and mortality rates were much lower than that of patients who had a thoracotomy, dropping from 42% for thoracotomies to 16% for thoracoscopies, the surgical approach being an independent predictive factor for postoperative complications (8).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Video-assisted Thoracoscopic Surgery (VATS) Segmentectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

patients undergo anatomic segmentectomy by video-assisted thoracoscopic surgery (VATS)
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

radiological evaluation

to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy

Group Type OTHER

thoracic densitometry with contrast

Intervention Type OTHER

injected CT scan at 3 or 6 months after segmentectomy VATS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

thoracic densitometry with contrast

injected CT scan at 3 or 6 months after segmentectomy VATS

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Enrolment in the study will be offered to all patients having undergone a programmed scheduled video-assisted thoracoscopic segmentectomy, whatever the aetiology.
* Men or women aged 18 years or greater
* Absence of severe hepatic insufficiency
* signed and dated informed consent
* candidate for segmentectomy
* Registration in a national healthcare system.
* Women of child-bearing age using effective oral or barrier contraception

Exclusion Criteria

* Proven intolerance to iodinated contrast agents
* Know allergy or non-controlled asthma - pregnancy
* Severe hepatic insufficiency (creatinine clearance \< 30ml/min, by Cockroft's method)
* Pregnant or breastfeeding women
* Patients under trusteeship or curators
* Diabetic patients or patients receiving oral antidiabetic medication
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Mutualiste Montsouris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Mutualiste montsouris

Paris, , France

Site Status RECRUITING

Institut mutualiste montsouris

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Agathe SEGUIN-GIVELET, MD

Role: CONTACT

0156616240

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Isabelle SAURET

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

THO-2016-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stellate Ganglion Block
NCT06271707 RECRUITING PHASE4